Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

CKD Hotspots: Challenges and Areas of Opportunity.

Obrador GT, Levin A.

Semin Nephrol. 2019 May;39(3):308-314. doi: 10.1016/j.semnephrol.2019.02.009. Review.

PMID:
31054631
2.

Introduction: CKD Hotspots.

Obrador GT, Levin A.

Semin Nephrol. 2019 May;39(3):227-229. doi: 10.1016/j.semnephrol.2019.02.010. No abstract available.

PMID:
31054621
3.

Current State and Challenges for Organ Donation and Transplantation in Mexico.

Reyes-Acevedo R, Obrador GT, Alberú-Gómez J, Gracida-Juárez C, André Madrigal J, Aburto-Morales S.

Transplantation. 2019 Apr;103(4):648-650. doi: 10.1097/TP.0000000000002474. No abstract available.

PMID:
30907851
4.

Strategies to improve monitoring disease progression, assessing cardiovascular risk, and defining prognostic biomarkers in chronic kidney disease.

Pena MJ, Stenvinkel P, Kretzler M, Adu D, Agarwal SK, Coresh J, Feldman HI, Fogo AB, Gansevoort RT, Harris DC, Jha V, Liu ZH, Luyckx VA, Massy ZA, Mehta R, Nelson RG, O'Donoghue DJ, Obrador GT, Roberts CJ, Sola L, Sumaili EK, Tatiyanupanwong S, Thomas B, Wiecek A, Parikh CR, Heerspink HJL.

Kidney Int Suppl (2011). 2017 Oct;7(2):107-113. doi: 10.1016/j.kisu.2017.07.005. Epub 2017 Sep 20. Review.

5.

Genetic and environmental risk factors for chronic kidney disease.

Obrador GT, Schultheiss UT, Kretzler M, Langham RG, Nangaku M, Pecoits-Filho R, Pollock C, Rossert J, Correa-Rotter R, Stenvinkel P, Walker R, Yang CW, Fox CS, Köttgen A.

Kidney Int Suppl (2011). 2017 Oct;7(2):88-106. doi: 10.1016/j.kisu.2017.07.004. Epub 2017 Sep 20. Review.

6.

The Provider's Role in Conservative Care and Advance Care Planning for Patients with ESRD.

Obrador GT.

Clin J Am Soc Nephrol. 2016 May 6;11(5):750-2. doi: 10.2215/CJN.03150316. Epub 2016 Apr 15. No abstract available.

7.

Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Macdougall IC, Bircher AJ, Eckardt KU, Obrador GT, Pollock CA, Stenvinkel P, Swinkels DW, Wanner C, Weiss G, Chertow GM; Conference Participants.

Kidney Int. 2016 Jan;89(1):28-39. doi: 10.1016/j.kint.2015.10.002.

8.

The Challenge of Providing Renal Replacement Therapy in Developing Countries: The Latin American Perspective.

Obrador GT, Rubilar X, Agazzi E, Estefan J.

Am J Kidney Dis. 2016 Mar;67(3):499-506. doi: 10.1053/j.ajkd.2015.08.033. Epub 2015 Dec 19.

PMID:
26709109
9.

Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care.

Davison SN, Levin A, Moss AH, Jha V, Brown EA, Brennan F, Murtagh FE, Naicker S, Germain MJ, O'Donoghue DJ, Morton RL, Obrador GT; Kidney Disease: Improving Global Outcomes.

Kidney Int. 2015 Sep;88(3):447-59. doi: 10.1038/ki.2015.110. Epub 2015 Apr 29.

10.

Clinical, histological and molecular characteristics of Mexican patients with Fabry disease and significant renal involvement.

Ramos-Kuri M, Olvera D, Morales JJ, Rodriguez-Espino BA, Lara-Mejía A, De Los Ríos D, Obrador GT, Granados J, Correa-Rotter R.

Arch Med Res. 2014 Apr;45(3):257-62. doi: 10.1016/j.arcmed.2014.03.005. Epub 2014 Mar 20.

PMID:
24656905
11.

Longitudinal analysis of participants in the KEEP Mexico's chronic kidney disease screening program.

Obrador GT, Villa AR, Olvera N, Gutiérrez V, Contreras D, Reyes R.

Arch Med Res. 2013 Nov;44(8):650-4. doi: 10.1016/j.arcmed.2013.10.006. Epub 2013 Nov 8.

PMID:
24211753
12.

How important is transfusion avoidance in 2013?

Macdougall IC, Obrador GT.

Nephrol Dial Transplant. 2013 May;28(5):1092-9. doi: 10.1093/ndt/gfs575. Epub 2013 Mar 13. Review.

PMID:
23486660
13.

Reaching targets for mineral metabolism clinical practice guidelines and its impact on outcomes among Mexican chronic dialysis patients.

Paniagua R, Ventura MD, Ávila-Díaz M, Hinojosa-Heredia H, Méndez-Duran A, Cisneros A, Gómez AM, Cueto-Manzano A, Trinidad P, Obrador GT, García-López E, Lindholm B.

Arch Med Res. 2013 Apr;44(3):229-34. doi: 10.1016/j.arcmed.2013.01.008. Epub 2013 Feb 8.

PMID:
23398790
14.

Effect of red cell transfusions on future kidney transplantation.

Obrador GT, Macdougall IC.

Clin J Am Soc Nephrol. 2013 May;8(5):852-60. doi: 10.2215/CJN.00020112. Epub 2012 Oct 18. Review.

15.

A decade after the KDOQI CKD guidelines: a perspective from Mexico.

Obrador GT, Paniagua R.

Am J Kidney Dis. 2012 Nov;60(5):736-7. doi: 10.1053/j.ajkd.2012.08.002. No abstract available.

PMID:
23067647
16.

Establishing the Global Kidney Disease Prevention Network (KDPN): a position statement from the National Kidney Foundation.

Obrador GT, Mahdavi-Mazdeh M, Collins AJ; Global Kidney Disease Prevention Network.

Am J Kidney Dis. 2011 Mar;57(3):361-70. doi: 10.1053/j.ajkd.2010.12.006. Review.

PMID:
21335246
17.

Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US.

Obrador GT, García-García G, Villa AR, Rubilar X, Olvera N, Ferreira E, Virgen M, Gutiérrez-Padilla JA, Plascencia-Alonso M, Mendoza-García M, Plascencia-Pérez S.

Kidney Int Suppl. 2010 Mar;(116):S2-8. doi: 10.1038/ki.2009.540.

PMID:
20186176
18.

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.

Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM; Kidney Disease: Improving Global Outcomes.

Kidney Int. 2010 Feb;77(4):299-311. doi: 10.1038/ki.2009.377. Epub 2009 Oct 21.

19.
20.

Fabry kidney disease.

Moran V, Obrador GT, Thadhani R.

Saudi J Kidney Dis Transpl. 2003 Jul-Sep;14(3):367-77.

21.

A report of the Lisbon Conference on the care of the kidney transplant recipient.

Abbud-Filho M, Adams PL, Alberú J, Cardella C, Chapman J, Cochat P, Cosio F, Danovitch G, Davis C, Gaston RS, Humar A, Hunsicker LG, Josephson MA, Kasiske B, Kirste G, Leichtman A, Munn S, Obrador GT, Tibell A, Wadström J, Zeier M, Delmonico FL.

Transplantation. 2007 Apr 27;83(8 Suppl):S1-22. No abstract available.

PMID:
17452912
22.

Effect of comorbidity on the increased mortality associated with early initiation of dialysis.

Kazmi WH, Gilbertson DT, Obrador GT, Guo H, Pereira BJ, Collins AJ, Kausz AT.

Am J Kidney Dis. 2005 Nov;46(5):887-96.

PMID:
16253729
23.

Trends in intravenous iron use among dialysis patients in the United States (1994-2002).

St Peter WL, Obrador GT, Roberts TL, Collins AJ.

Am J Kidney Dis. 2005 Oct;46(4):650-60.

PMID:
16183420
24.

Carnitine therapy is associated with decreased hospital utilization among hemodialysis patients.

Kazmi WH, Obrador GT, Sternberg M, Lindberg J, Schreiber B, Lewis V, Pereira BJ.

Am J Nephrol. 2005 Mar-Apr;25(2):106-15. Epub 2005 Mar 10. Review.

PMID:
15802898
25.

Does predialysis nephrology care influence patient survival after initiation of dialysis?

Khan SS, Xue JL, Kazmi WH, Gilbertson DT, Obrador GT, Pereira BJ, Collins AJ.

Kidney Int. 2005 Mar;67(3):1038-46.

26.

Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients.

Roberts TL, Obrador GT, St Peter WL, Pereira BJ, Collins AJ.

Kidney Int. 2004 Dec;66(6):2429-36.

27.

Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis.

Kazmi WH, Obrador GT, Khan SS, Pereira BJ, Kausz AT.

Nephrol Dial Transplant. 2004 Jul;19(7):1808-14.

PMID:
15199194
28.

Prevalence of malnutrition in low-income Mexican CAPD patients.

Garcia-Garcia G, Nuñez-Martinez MG, Obrador GT.

Perit Dial Int. 2003 Sep-Oct;23(5):501-4. No abstract available.

PMID:
14604206
29.

Chronic kidney disease in the United States: an underrecognized problem.

Obrador GT, Pereira BJ, Kausz AT.

Semin Nephrol. 2002 Nov;22(6):441-8. Review.

PMID:
12430088
30.

Anaemia of chronic kidney disease: an under-recognized and under-treated problem.

Obrador GT, Pereira BJ.

Nephrol Dial Transplant. 2002;17 Suppl 11:44-6. Review.

PMID:
12386258
31.

End-stage renal disease in patients with Fabry disease.

Obrador GT, Ojo A, Thadhani R.

J Am Soc Nephrol. 2002 Jun;13 Suppl 2:S144-6. Review. No abstract available.

32.

Systemic complications of chronic kidney disease. Pinpointing clinical manifestations and best management.

Obrador GT, Pereira BJ.

Postgrad Med. 2002 Feb;111(2):115-22; quiz 21. Review.

PMID:
11868308
33.

Patients with Fabry disease on dialysis in the United States.

Thadhani R, Wolf M, West ML, Tonelli M, Ruthazer R, Pastores GM, Obrador GT.

Kidney Int. 2002 Jan;61(1):249-55.

34.

Trends in anemia at initiation of dialysis in the United States.

Obrador GT, Roberts T, St Peter WL, Frazier E, Pereira BJ, Collins AJ.

Kidney Int. 2001 Nov;60(5):1875-84.

35.

Anemia: an early complication of chronic renal insufficiency.

Kazmi WH, Kausz AT, Khan S, Abichandani R, Ruthazer R, Obrador GT, Pereira BJ.

Am J Kidney Dis. 2001 Oct;38(4):803-12.

PMID:
11576884
36.

Pre-end-stage renal disease care in the United States: a state of disrepair.

Obrador GT, Arora P, Kausz AT, Pereira BJ.

J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S44-54. Review.

PMID:
11443767
37.

Management of patients with chronic renal insufficiency in the Northeastern United States.

Kausz AT, Khan SS, Abichandani R, Kazmi WH, Obrador GT, Ruthazer R, Pereira BJ.

J Am Soc Nephrol. 2001 Jul;12(7):1501-7.

38.

Late initiation of dialysis among women and ethnic minorities in the United States.

Kausz AT, Obrador GT, Arora P, Ruthazer R, Levey AS, Pereira BJ.

J Am Soc Nephrol. 2000 Dec;11(12):2351-7.

39.

Initiation of dialysis: current trends and the case for timely initiation.

Obrador GT, Pereira BJ.

Perit Dial Int. 2000;20 Suppl 2:S142-9. Review. No abstract available.

PMID:
10911660
40.

Hospital utilization among chronic dialysis patients.

Arora P, Kausz AT, Obrador GT, Ruthazer R, Khan S, Jenuleson CS, Meyer KB, Pereira BJ.

J Am Soc Nephrol. 2000 Apr;11(4):740-6.

41.

Anemia management in patients with chronic renal insufficiency.

Kausz AT, Obrador GT, Pereira BJ.

Am J Kidney Dis. 2000 Dec;36(6 Suppl 3):S39-51. Review.

PMID:
11118157
42.

Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population.

Obrador GT, Arora P, Kausz AT, Ruthazer R, Pereira BJ, Levey AS.

Kidney Int. 1999 Dec;56(6):2227-35.

43.

Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States.

Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJ.

J Am Soc Nephrol. 1999 Aug;10(8):1793-800.

44.

Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center.

Arora P, Obrador GT, Ruthazer R, Kausz AT, Meyer KB, Jenuleson CS, Pereira BJ.

J Am Soc Nephrol. 1999 Jun;10(6):1281-6.

46.

Acute renal failure due to lymphomatous infiltration of the kidneys.

Obrador GT, Price B, O'Meara Y, Salant DJ.

J Am Soc Nephrol. 1997 Aug;8(8):1348-54.

47.

Frontiers in Internal Medicine.

Lopez-Jimenez F, Luna-Jimenez MA, Polanczyk CA, Rohde LE, Rivera-Moscoso R, Reza-Albarran AA, Macias-Hernandez AE, Obrador GT, Levey AS, Mora R.

Arch Med Res. 1997 Winter;28(4):473-88. Review.

PMID:
9428570
48.

Spinal epidural abscess in hemodialysis patients: report of three cases and review of the literature.

Obrador GT, Levenson DJ.

Am J Kidney Dis. 1996 Jan;27(1):75-83. Review.

PMID:
8546141
49.

Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura.

Obrador GT, Zeigler ZR, Shadduck RK, Rosenfeld CS, Hanrahan JB.

Am J Hematol. 1993 Feb;42(2):217-20.

PMID:
8438882

Supplemental Content

Loading ...
Support Center